Find clinical trials for Pancreatic Cancer in London, England
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near London, England, GBR:
This is an open-label, multi-centre, randomised, stratified, phase IIb clinical trial of ATRA administered in combination with gemcitabine and nab-pa...
Phase 2
London, United Kingdom
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
London, United Kingdom and 55 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
London, City Of London, United Kingdom and 91 other locations
is to assess the safety and efficacy of OncoSil™ when given in addition to standard FOLFIRINOX chemotherapy for treatment of Locally Advanced Pancreatic...
Phase 2
London, United Kingdom and 16 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...
Phase 2
London, Other, United Kingdom and 71 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....
Phase 1, Phase 2
Sutton, United Kingdom and 76 other locations
This is a multi-centre, investigator-initiated, dose escalation, Phase I trial of the combination of the FAK inhibitor, Defactinib (VS-6063), and the...
Phase 1
London, United Kingdom and 4 other locations
to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...
Phase 2
London, United Kingdom and 64 other locations
This study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder. This is a study for people for ...
Phase 2
London, United Kingdom and 42 other locations
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...
Phase 2
London, United Kingdom and 122 other locations
Clinical trials
Research sites
Resources
Legal